首页> 外文会议>2011 International Conference on Human Health and Biomedical Engineering >Application of CD4+ CD25+ T regulatory cells in trachea allograft transplant model of mice to reject anti-graft response
【24h】

Application of CD4+ CD25+ T regulatory cells in trachea allograft transplant model of mice to reject anti-graft response

机译:CD4 + CD25 + T调节细胞在小鼠气管异体移植模型中的抗排斥反应应用

获取原文

摘要

To study the role of CD4+ CD25+ Treg cells in anti-graft rejection response and potential value in application of lung transplatation, we established mice trachea allograft transplant model and sort CD4+ CD25+ Treg cells from mice spleen lymphocytes by MACS. FCM assays were done to analyze the ratio of marker protein, Foxp3, expression in CD4+ CD25+ Treg cells. Alveolar cells were used as a non-specific antigen to activate iDCs into mDCs, and cocultureed with CD4+ CD25+ Treg cells to activate Treg cells. The activated Treg cells were inject into mice with trachea allograft transplantation to reduce rejection response. The allografts were extracted and done pathological examination with H&E staining. The purity of CD4+ CD25+ Treg cells were over 80% and specifically express Foxp3, the organizational structure of implanted trachea showed that the tracheal structure was intact. Our research imply that CD4+ CD25+ Treg cells play an essential role in reducing rejection, and lay the foundation for reject anti-graft response in clinical application.
机译:为了研究CD4 + / sup> cd25 + / sup> Treg细胞在抗移植物排斥反应中的特雷格细胞和应用肺移植的潜在值,我们建立了小鼠气管同种异体移植移植模型并排序CD4 + cd25 + 来自mics的小鼠脾淋巴细胞的Treg细胞。进行FCM测定以分析标记蛋白,FoxP3,CD4 + / sup> CD25 + Treg细胞中的表达的比例。使用肺泡细胞作为非特异性抗原以使IDC活化到MDC中,并用CD4 + / sop> CD25 + Treg细胞以激活Treg细胞。将活化的Treg细胞用气管同种异体移植移植注射到小鼠中以减少排斥反应。提取同种异体移植物并用H&E染色完成病理检查。 CD4 + cd25 + Treg细胞的纯度超过80%,特别是表达Foxp3,植入气管的组织结构表明气管结构完好无损。我们的研究意味着CD4 + CD25 + Treg细胞在减少排斥方面发挥着基本作用,并为临床应用中排出抗移植反应的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号